Free Trial

Ardelyx (ARDX) Short Interest Ratio & Short Volume

$6.58
-0.11 (-1.64%)
(As of 11:44 AM ET)

Ardelyx Short Interest Data

Current Short Interest
30,940,000 shares
Previous Short Interest
33,040,000 shares
Change Vs. Previous Month
-6.36%
Dollar Volume Sold Short
$212.25 million
Short Interest Ratio
6.0 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
232,700,000 shares
Percentage of Shares Shorted
13.30%
Today's Trading Volume
1,028,672 shares
Average Trading Volume
5,688,060 shares
Today's Volume Vs. Average
18%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ardelyx ?

Sign up to receive the latest short interest report for Ardelyx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARDX Short Interest Over Time

ARDX Days to Cover Over Time

ARDX Percentage of Float Shorted Over Time

Ardelyx Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202430,940,000 shares $212.25 million -6.4%N/A6 $6.86
5/15/202433,040,000 shares $259.36 million -6.1%N/A5.9 $7.85
4/30/202435,170,000 shares $225.09 million +3.7%N/A5.9 $6.40
4/15/202433,930,000 shares $230.72 million -3.1%N/A6.2 $6.80
3/31/202435,020,000 shares $255.65 million -3.6%N/A5.5 $7.30
3/15/202436,310,000 shares $294.11 million +8.0%N/A5.8 $8.10
2/29/202433,610,000 shares $313.25 million +11.8%N/A5.1 $9.32
2/15/202430,060,000 shares $279.56 million +6.8%N/A4.7 $9.30
1/31/202428,160,000 shares $245.84 million -3.0%N/A4.7 $8.73
1/15/202429,020,000 shares $262.05 million -12.0%N/A4.5 $9.03
12/31/202332,980,000 shares $204.48 million +0.2%N/A4.6 $6.20
12/15/202332,930,000 shares $194.62 million -8.7%N/A5.1 $5.91
11/30/202336,080,000 shares $162.72 million -5.4%N/A5.7 $4.51
11/15/202338,120,000 shares $147.52 million +4.5%N/A5.6 $3.87
10/31/202336,470,000 shares $144.06 million +50.0%N/A5.4 $3.95
10/15/202324,310,000 shares $80.95 million +9.7%N/A3.8 $3.33
9/30/202322,170,000 shares $90.45 million -9.6%N/A4.6 $4.08
9/15/202324,510,000 shares $111.52 million -4.9%N/A4.6 $4.55
8/31/202325,770,000 shares $109.78 million -7.1%N/A5 $4.26
8/15/202327,750,000 shares $106.84 million +0.2%N/A6 $3.85
7/31/202327,700,000 shares $109.14 million +4.3%N/A5.5 $3.94
7/15/202326,560,000 shares $90.30 million +1.7%N/A5.2 $3.40
6/30/202326,130,000 shares $88.58 million +42.0%N/A4.7 $3.39
6/15/202318,400,000 shares $72.13 million +7.3%N/A3.1 $3.92
5/31/202317,150,000 shares $57.28 million +2.8%N/A2.8 $3.34
5/15/202316,690,000 shares $74.44 million -8.5%N/A2.3 $4.46
4/30/202318,240,000 shares $81.35 million -4.0%N/A2.6 $4.46
4/15/202319,000,000 shares $89.49 million +7.2%N/A2.7 $4.71
3/31/202317,720,000 shares $84.88 million +36.4%N/A2.4 $4.79
3/15/202312,990,000 shares $51.83 million +18.2%N/A1.6 $3.99
2/28/202310,990,000 shares $31.65 million +8.7%N/A1.4 $2.88
2/15/202310,110,000 shares $30.53 million -4.4%N/A1.4 $3.02
1/31/202310,580,000 shares $31.00 million -9.5%N/A1 $2.93
1/15/202311,690,000 shares $36.94 million -5.5%N/A1.1 $3.16
12/30/202212,370,000 shares $35.25 million +17.6%N/A1.3 $2.85
12/15/202210,520,000 shares $20.41 million -15.2%N/A1.2 $1.94
11/30/202212,410,000 shares $21.35 million +44.5%N/A1.5 $1.72
11/15/20228,590,000 shares $10.48 million +17.0%N/A1.1 $1.22
10/31/20227,340,000 shares $11.01 million -7.6%N/A2.1 $1.50
10/15/20227,940,000 shares $10.96 million +2.1%N/A2.4 $1.38
Nvidia is now part of $3 Trillion Market Cap Club (Ad)

A small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown right now, but that won’t be the case much longer.

Click here to find out who they are today.
9/30/20227,780,000 shares $9.26 million +12.9%N/A2.4 $1.19
9/15/20226,890,000 shares $9.44 million -14.9%N/A2.1 $1.37
8/31/20228,100,000 shares $7.68 million -4.0%N/A2.5 $0.95
8/15/20228,440,000 shares $8.19 million -22.4%N/A3.4 $0.97
7/31/202210,880,000 shares $7.59 million +0.4%N/A4.5 $0.70
7/15/202210,840,000 shares $7.58 million +3.5%N/A3.4 $0.70
6/30/202210,470,000 shares $6.18 million -13.9%N/A3.1 $0.59
6/15/202212,160,000 shares $6.66 million -6.2%N/A3.4 $0.55
5/31/202212,960,000 shares $8.50 million +11.2%N/A4 $0.66
5/15/202211,660,000 shares $7.62 million +1.0%N/A3.3 $0.65
4/30/202211,540,000 shares $9.50 million +20.0%N/A3.2 $0.82
4/15/20229,620,000 shares $8.59 million -1.4%N/A2.7 $0.89
3/31/20229,760,000 shares $10.44 million +3.7%N/A3.1 $1.07
3/15/20229,410,000 shares $8.65 million +9.8%N/A2.5 $0.92
2/28/20228,570,000 shares $6.60 million +1.1%N/A1.1 $0.77
2/15/20228,480,000 shares $6.21 million +15.9%N/A0.5 $0.73
1/31/20227,320,000 shares $6.05 million -7.0%N/A0.4 $0.83
1/15/20227,870,000 shares $7.33 million -1.8%N/A0.5 $0.93
12/31/20218,010,000 shares $8.81 million -34.5%N/A0.5 $1.10
12/15/202112,230,000 shares $14.68 million +92.9%13.1%0.7 $1.20
11/30/20216,340,000 shares $7.23 million +7.6%6.9%0.4 $1.14
11/15/20215,890,000 shares $6.60 million -23.4%6.5%1.7 $1.12
10/29/20217,690,000 shares $9.30 million +18.5%9.3%1.9 $1.21
10/15/20216,490,000 shares $7.01 million -2.0%7.7%0.9 $1.08
9/30/20216,620,000 shares $8.74 million -16.0%7.8%0.6 $1.32
9/15/20217,880,000 shares $10.01 million -8.8%9.3%0.8 $1.27
8/31/20218,640,000 shares $12.18 million -15.5%10.3%0.8 $1.41
8/13/202110,230,000 shares $14.73 million -3.4%13.1%1.1 $1.44
7/30/202110,590,000 shares $18.43 million +7.2%14.2%1.2 $1.74
7/15/20219,880,000 shares $74.00 million +8.1%13.2%1.7 $7.49
6/30/20219,140,000 shares $69.28 million +20.9%12.3%4.1 $7.58
6/15/20217,560,000 shares $55.19 million -10.0%10.1%3.4 $7.30
5/28/20218,400,000 shares $60.06 million -10.1%11.3%3.9 $7.15
5/14/20219,340,000 shares $62.02 million +5.2%N/A4.4 $6.64
4/30/20218,880,000 shares $74.86 million -11.4%N/A4.4 $8.43
4/15/202110,020,000 shares $78.56 million +13.1%N/A6.2 $7.84
3/31/20218,860,000 shares $54.93 million +54.4%N/A8.3 $6.20
3/15/20215,740,000 shares $40.01 million +23.7%N/A6.7 $6.97
2/26/20214,640,000 shares $30.02 million -4.1%N/A5.7 $6.47
2/12/20214,840,000 shares $35.19 million +4.5%N/A6.5 $7.27
1/29/20214,630,000 shares $31.81 million +2.2%N/A6.7 $6.87
1/15/20214,530,000 shares $31.39 million -5.2%N/A6.9 $6.93
12/31/20204,780,000 shares $32.17 million -4.0%N/A8.1 $6.73
12/15/20204,980,000 shares $34.26 million -14.6%N/A9.1 $6.88
11/30/20205,830,000 shares $36.79 million +13.0%N/A12 $6.31
11/15/20205,160,000 shares $29.88 million -9.3%N/A10.7 $5.79
10/30/20205,690,000 shares $29.76 million +12.7%N/A12 $5.23
10/15/20205,050,000 shares $28.46 million -8.0%N/A10.1 $5.64
9/30/20205,490,000 shares $28.82 million -7.3%N/A0 $5.25
9/15/20205,920,000 shares $36.05 million -6.6%N/A9.5 $6.09
Nvidia is now part of $3 Trillion Market Cap Club (Ad)

A small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown right now, but that won’t be the case much longer.

Click here to find out who they are today.
8/31/20206,340,000 shares $36.39 million -2.5%N/A10.2 $5.74
8/14/20206,500,000 shares $36.47 million +9.4%N/A9.9 $5.61
7/31/20205,940,000 shares $33.56 million -3.6%N/A8.3 $5.65
7/15/20206,160,000 shares $39.36 million +13.2%N/A8.4 $6.39
6/30/20205,440,000 shares $37.64 million +68.9%N/A7.1 $6.92
6/15/20203,220,000 shares $21.22 million +10.3%N/A4.4 $6.59
5/29/20202,920,000 shares $21.40 million +4.3%N/A3.8 $7.33
5/15/20202,800,000 shares $20.78 million +0.4%N/A3.5 $7.42
4/30/20202,790,000 shares $18.36 million -5.7%N/A3.2 $6.58
4/15/20202,960,000 shares $19.80 million -2.6%N/A3.5 $6.69
3/31/20203,040,000 shares $22.89 million -13.5%N/A3.6 $7.53
3/13/20203,514,700 shares $21.30 million +9.5%N/A4.4 $6.06
2/28/20203,210,000 shares $18.49 million +14.2%N/A3.7 $5.76
2/14/20202,810,000 shares $17.53 million +10.6%N/A2.7 $6.24
1/31/20202,540,000 shares $17.37 million +6.7%N/A2.6 $6.84
1/15/20202,380,000 shares $17.68 million -39.6%N/A2.6 $7.43
12/31/20193,940,000 shares $27.93 million +42.8%6.3%4.4 $7.09

ARDX Short Interest - Frequently Asked Questions

What is Ardelyx's current short interest?

Short interest is the volume of Ardelyx shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 30,940,000 shares of ARDX short. Learn More on Ardelyx's current short interest.

What is a good short interest ratio for Ardelyx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARDX shares currently have a short interest ratio of 6.0. Learn More on Ardelyx's short interest ratio.

Which institutional investors are shorting Ardelyx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ardelyx: Jane Street Group LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Ardelyx's short interest increasing or decreasing?

Ardelyx saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 30,940,000 shares, a decline of 6.4% from the previous total of 33,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ardelyx's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ardelyx: Mirum Pharmaceuticals, Inc. (18.88%), OPKO Health, Inc. (26.47%), 89bio, Inc. (10.75%), XBiotech Inc. (3.35%), Ionis Pharmaceuticals, Inc. (6.41%), Cytokinetics, Incorporated (14.86%), Summit Therapeutics Inc. (25.62%), Madrigal Pharmaceuticals, Inc. (24.54%), Organon & Co. (3.14%), BridgeBio Pharma, Inc. (11.87%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Ardelyx stock?

Short selling ARDX is an investing strategy that aims to generate trading profit from Ardelyx as its price is falling. ARDX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ardelyx?

A short squeeze for Ardelyx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDX, which in turn drives the price of the stock up even further.

How often is Ardelyx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDX, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ARDX) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners